| Net Cash Provided by (Used in) Operating Activities |
$23,689,000 |
USD |
-191% |
Q1 2024 |
Q1 2024 |
| Net Cash Provided by (Used in) Financing Activities |
$22,740,000 |
USD |
|
Q1 2024 |
Q1 2024 |
| Net Cash Provided by (Used in) Investing Activities |
$1,855,000 |
USD |
61% |
Q1 2024 |
Q1 2024 |
| Common Stock, Shares Authorized |
35,000,000 |
shares |
0% |
Q1 2024 |
Q1 2024 |
| Common Stock, Shares, Issued |
31,389,000 |
shares |
1.5% |
Q1 2024 |
Q1 2024 |
| Common Stock, Par or Stated Value Per Share |
0 |
USD/shares |
0% |
Q1 2024 |
Q1 2024 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect |
$2,804,000 |
USD |
27% |
Q1 2024 |
Q1 2024 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
$5,968,000 |
USD |
-14% |
Q1 2024 |
Q1 2024 |
| Interest Paid, Excluding Capitalized Interest, Operating Activities |
$1,823,000 |
USD |
57% |
Q1 2024 |
Q1 2024 |
| Deferred Tax Assets, Valuation Allowance |
$42,900,000 |
USD |
|
Q1 2024 |
Q1 2024 |
| Payments to Acquire Property, Plant, and Equipment |
$1,861,000 |
USD |
-61% |
Q1 2024 |
Q1 2024 |
| Operating Lease, Liability, Current |
$32,083,000 |
USD |
5% |
Q1 2024 |
Q1 2024 |
| Depreciation, Depletion and Amortization |
$4,761,000 |
USD |
2% |
Q1 2024 |
Q1 2024 |
| Deferred Tax Assets, Net of Valuation Allowance |
$42,600,000 |
USD |
|
Q1 2024 |
Q1 2024 |